Abstract: CD147 plays a critical role in the invasive and metastatic activity of hepatocellular carcinoma (HCC) cells by stimulating the surrounding fibroblasts to secrete matrix metalloproteinases (MMPs). Tumor cells adhesion to extracellular matrix (ECM) proteins is the first step to the tumor metastasis. MMPs degrade the ECM to promote tumor metastasis. The aim of this research was to investigate the inhibitory effects of stealth small interfering RNA (siRNA) against CD147 on HCC cell line (SMMC-7721) metastatic properties including invasion, adhesion to ECM, gelatinase production, focal adhesion kinase (FAK) and vinculin expression. Flow cytometry (FCM) and western blot assays were employed to detect the transfection efficiency of the stealth siRNA against CD147. Invasion assays and gelatin zymography were also used to detect the effects of stealth siRNA against CD147 on SMMC-7721 cells' invasion and gelatinase production. The effects of stealth siRNA against CD147 on FAK and vinculiln expression in SMMC-7721 cells were also detected by western blot. The results showed that stealth siRNA against CD147 inhibited SMMC-7721 invasion, adhesion to ECM proteins, MMP-2 production, and FAK and vinculin expression. These findings indicate that CD147 is required for tumor cell invasion and adhesion. Perturbation of CD147 expression may have potential therapeutic uses in the prevention of MMP-2-dependent tumor invasion.
Introduction
The metastatic process of tumor cells is a very complex process that involves both the characteristics of the malignant cells and their interaction with the cellular and extracellular environments (Polette et al. 2004) . Tumor cell adhesion to the extracellular matrix (ECM) within tissues greatly affects the ability of a malignant cell to attack and metastasize to outlying tissues. Furthermore, the survival of the metastasized tumor cell partly relies on the activity of the ECM receptors (Sethi et al. 1999; Streuli & Gilmore 1999) . Matrix metalloproteinases (MMPs) may modulate cell adhesion and invasion, which can allow cells to move through the ECM (Yoon et al. 2003; Demers et al. 2005) . The abnormal activation of MMP in tissue can stimulate ECM degradation and promote tumor cell metastasis (Stamenkovic 2003; Rundhaug 2005) . Matrix metalloproteinase-2 (MMP-2) has been regarded as a crucial enzyme for tumor progression, invasion and metastasis. Recent studies have reported that tumor cells utilize MMPs, e.g, MMP-2 produced by adjacent stromal cells, such as fibroblasts or endothelial cells, to promote tumor progression, invasion and metastasis (Zhang et al. 2006) . In many solid tumors, MMPs are indeed produced by tumor stromal cells, rather than by tumor cells . The expression pattern is, at least in part, regulated by tumor-stroma interaction via tumor cell associated extracellular matrix metalloproteinase inducer (EMMPRIN) (Tang et al. 2004) .
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of mankind. At present many advances in HCC's clinical study have been made, but the prognosis of HCC is still gloomy. It is important for tumor control to distinguish the factors that predispose patients to death. With new discoveries in cancer biology, the pathological and biological prognostic factors of HCC have been studied quite extensively. A large number of biomarkers have been shown to associate with the invasiveness of HCC, and have potential prognostic significance (Tang 2001; Qin & siRNA against CD147 inhibits HCC cell functions 757 Tang 2002; Zhang et al. 2002; Kulik 2007; Nishiguchi 2007) .
Recently, it has been reported that CD147 could be used as a marker to judge the invasion and metastasis of HCC Zhang et al. 2007) . CD147, also known as EMMPRIN, OX-47, HT7 and basigin, is a member of the immunoglobulin superfamily that is overexpressed on the surface of tumor cells and stimulates adjacent stromal cells to produce MMPs (Guo et al. 2001; Muramatsu & Miyauchi 2003) . CD147 is a highly glycosylated transmembrane protein of 60 kDa with an ectodomain consisting of two regions exhibiting the characteristics of the immunoglobulin superfamily (Li et al. 2001) . Our previous studies demonstrated that HAb18G/CD147 stimulated fibroblast cells to produce elevated levels of several MMPs, including MMP-1, MMP-2, and MMP-9, which are wellknown for prompting invasion of HCC cells, and antisense RNA of HAb18G/CD147 inhibited the invasion of HCC cells in vitro (Li et al. 2003) . Recently our studies showed that double-stranded RNA (dsRNA) targeted for CD147 inhibited MMP-2 secretion and focal adhesion kinase (FAK) expression in HCC cell line FHCC98 via extracellular signal-regulated kinase 1/2 (ERK1/2 pathway) ). Downregulation of CD147 inhibits HCC cell invasion, adhesion and induces cytoskeletal alteration (AiRong Qian, unpublished results). The microarray results showed that downregulation of CD147 gene led to signal transduction proteins alteration, such as mitogen-activated protein kinase kinase 1 (MEK1) interacting protein 1 (AiRong Qian, unpublished results).
Stealth TM RNAi is modified dsRNA developed to overcome the limitations of traditional small interfering RNA (siRNA). Stealth TM RNAi often eliminates nonspecific effects such as the dsRNA-dependent protein kinase/interferon stress response caused by siRNA. Nonspecific effects such as stress responses result in growth inhibition and cytotoxicity, making RNAi results extremely difficult to interpret. Stealth TM RNAi is the only modified dsRNA that effectively avoids recognition by complexes that initiate cellular stress responses, while offering highly potent gene knockdown via RNAi.
Our goal in this study was therefore to investigate the effects of stealth si-CD147 on invasive and adhesive abilities, and gelatinase production of SMMC-7721 cells. Meanwhile, the expression of FAK and vinculin in SMMC-7721 cells were also detected. The data here indicate that perturbation of CD147 expression may have potential therapeutic uses in the prevention of MMP-2-dependent tumor invasion.
Material and methods

Cell culture
The human HCC cell line SMMC-7721 (Cell Collection Center of Shanghai, Shanghai, People's Republic of China) was grown in RMPI 1640 culture medium (Invitrogen Corporation, California, USA) supplemented with 10% heat inactivated calf bovine serum (Hyclone, Utah, USA) and penicillin (100 units/mL)/streptomycin (100 units/mL) at 37
• C, 5% CO2 in a humidified incubator (Heraeus Comp, Germany).
Stealth siRNA synthesis and transfection Three sets of stealth select RNAi oligos targeting CD147 (stealth si-CD147, GenBank Acc. No. AF320819; HSS1413-94, HSS141395 and HSS141396) were designed and synthesized by Invitrogen Life Technologies. The sequences were as follows: HSS141394: sense 5'-UGAUGGUGACCAGCACCAGCACCUC-3', anti-sense 5'-GAGGUGCUGGUGCUGGUCACCAUCA-3'. HSS141395: sense 5'-UUCUGACGACUUCACAGCCUUCACU-3', anti-sense 5'-AGUGAAGGCUGUGAAGUCGUCAGAAA-3'. HSS141396: sense 5'-AACUCACGAAGAACCUGCUCUCGGA-3', anti-sense 5'-UCCGAGAGCAGGUUCUUCGUGAGUU-3'.
As a negative control, we used stealth TM RNAi Negative Control Hi GC (control siRNA, Invitrogen Life Technologies, California, USA). RNAi oligos were transfected at a concentration of 100 pmol in 6-well plate (Nunc Inc in Denmark) by using LipofectAMINE 2000 reagent (Invitrogen Life Technologies, California, USA). SMMC-7721 cells were trypsinized and added into 6-well plate. Cells were cultured with growth medium without antibiotics until the 90% confluent at the time of transfection. 100 pmol stealth si-CD147 and 5 µL lipofectAMINE 2000 was respectively added to 250 µL Opti-MEM (Invitrogen Life Technologies, California, USA). After the 5 min incubation, the diluted stealth si-CD147 and lipofectamine 2000 were mixed gently and incubated for 20 min at room temperature to allow complex formation to occur. The RNAi-lipofectAMINE 2000 complexes were added to each well containing cells and medium, and then were mixed gently. The cells were incubated at 37
• C in a humidified atmosphere of 5% CO2 for 48 h.
Flow cytometric analysis of transfection efficiency of stealth siRNA After being transfected by stealth si-CD147 and control siRNA for 48 h, SMMC-7721 cells were collected and labeled with anti-CD147 (BD Pharmingen, USA) for 1 h at room temperature. Cells were washed three-times and co-cultured with goat anti-mouse IgG-FITC (1:100, KPL, Oklahoma, USA) at 4
• C in dark for 30 min. The cells were subjected to flow cytometry (FCM) analysis using a FACSCalibur flow cytometer and CellQuest software (BD Biosciences, California, USA).
Western blot analysis of CD147, FAK and vinculin expression in SMMC-7721 cells after being transfected with stealth siRNA SMMC-7721 cells transfected with stealth si-CD147 or control siRNA suspension were collected, and centrifuged at 800 r/min. The cell pellets were collected and re-suspended in lysis buffer, and the lysis solution was centrifuged at 16,000 × g for 10 min at 4
• C. The supernatants were collected, and the protein concentration was detected with BCA kit (Pierce Chemical Company, USA). Equal total protein loads of 100 µg were loaded on the lanes of the SDS-polyacrylamide gel and separated by electrophoresis. Protein marker (Li-COR Bioscience, Nebraska, USA) as the molecular weight ladders was loaded at the same time. The proteins were then transferred to PVDF membrane (Immobilon-P, Millipore, Massachusetts, USA). After being blocked with Odyssey blocking buffer (Li-COR Bioscience, Nebraska, USA), the blots were incubated overnight with anti-CD147 (BD Pharmingen, USA), anti-FAK (sigma Company, USA) and anti-vinculin (Merck-Calbiochem, California, USA) at 4
• C. Blots were washed for 5 min threetimes with Tris-buffered saline/0.1% Tween-20 and incubated with IRDye TM 800-labeled secondary antibodies (1:5000, Li-COR Bioscience, Nebraska, USA) for 1 h and identical lysates were reprobed with a GAPDH antibody (Chemicon, California, USA) as a loading control. The membranes were washed as above, and the bands were scanned by Odyssey Infrared Imaging System (Li-COR Bioscience, Nebraska, USA).
Gelatin zymography analysis of gelatinase production in SMMC-7721 cells after being transfected with stealth siRNA After SMMC-7721 cells transfected with stealth si-CD147 were cultured for 48 h, conditioned medium was collected and separated by 8% acrylamide gels containing 0.1% gelatin. The gels were incubated in 2.5% Triton X-100 solution at room temperature with gentle agitation to remove SDS and were soaked in reaction buffer 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, 10 mM CaCl2, at 37
• C overnight. After reaction, the gels were stained for 6 h with staining solution and destained for 0.5 h. Gelatinolytic activity of MMPs was visualized as a clear band against a dark background of stained gelatin.
Detection of SMMC-7721 cells' adhesive abilities after being transfected with stealth siRNA SMMC-7721 cells transfected with stealth si-CD147 were suspended and added in 96-well micro-plates coated with fibronectin (FN), laminin (LN), and collagen IV (3 µg per well, BD Biosciences, California, USA). After the cells were allowed to adhere for 1 h at 37
• C, the cells were washed three-times with PBS and fixed with 4% formaldehyde. The cells were then stained with 0.5% crystal violet in 20% (v/v) methanol/water and viewed under a microscope. The number of bound cells was estimated by solubilizing the dye using 0.1 M sodium citrate and the absorbance was read at 490 nm. Triplicate determinations were done at each data point.
Detection of SMMC-7721cells' invasive abilities after being transfected with stealth siRNA In vitro invasion assay was performed by using millicell inserts with polycarbonate filters (pore size, 8 µm, Millipore Company). The upper side of polycarbonate filter was coated with Matrigel (0.6 mg/mL, BD Biosciences, California, USA) to form a continuous thin layer. Prior to the addition of cell suspension, the dried layer of matrigel matrix was rehydrated with medium without serum for 2 h at room temperature. The cells transfected with stealth si-CD147 were harvested and 2.2 × 10 5 cells in 300 µL of 0.1% serum-medium were placed in the upper chamber. The lower chamber was filled with 0.1% serum-medium (200 µL) and serum-free conditioned medium from NIH/3T3 (300 µL). Cells were cultured for 24 h at 37
• C in 5% CO2. After incubation, the cells were washed three-times with RPMI1640 and were then fixed by immersing the chambers in 95% methanol for 10 min. Cells on the upper surface were removed with a cotton swab and were stained with Hematoxylin and Eosin (Sino-American Biotechnology Company, Xi'an, People's Republic of China). Cells migrated on the underside of the membrane were counted microscopically. The determinations were done in triplicate.
Statistical analysis
Statistically significant differences were determined using Prism statistical software (GraphPad Software, Inc., California, USA). P < 0.05 was considered significant in all cases. All data averages or means are accompanied by standard deviations to indicate the amount of variability in the data. In addition, standard errors of the means were also calculated since they were useful in comparing means from different test groups.
Results
Stealth siRNA inhibits CD147 expression in SMMC-7721 cells In order to investigate the transfection efficiency of 3 sets of stealth si-CD147 (HSS141394, HSS141395 and HSS141396), FCM and western blot assays were employed. The results of FCM showed that HSS141394, HSS141395 and HSS141396 all dramatically inhibited CD147 expression with the inhibitory rate 77.22%, 73.22% and 73.22%, respectively (Fig 1A) . The results of western blot showed that 3 sets of stealth si-CD147 also significantly inhibited CD147 expression in SMMC-7721 cells. Moreover, the inhibitory effect of HSS141394 was most obvious compared with that of others (Fig. 1B) .
Stealth siRNA against CD147 blocks gelatinase production The effects of 3 sets of stealth si-CD147 on gelatinase production in SMMC-7721 cells were examined by gelatin zymography. The results showed that MMP-2 production in SMMC-7721 cells transfected with HSS141394, HSS141395 and HSS141396 was significantly decreased compared with that in control cells, and the inhibitory rate was 68.5%, 75.91% and 63.7%, respectively (Fig. 2) .
Stealth siRNA against CD147 inhibits SMMC-7721 cells adhesion to ECM proteins
The effects of 3 sets of stealth si-CD147 on the adhesive abilities of HCC cells on ECM proteins including FN, LN and collagne IV were detected by adhesion assays. The results indicated that HSS141394, HSS141395 and HSS141396 all significantly inhibited the adhesive abilities of SMMC-7721 cells on ECM proteins including FN, LN and collagne IV (P < 0.05). Moreover, the inhibitory effect of HSS141394 was most obvious compared with that of others (Fig. 3) .
Stealth siRNA against CD147 inhibits SMMC-7721 cells' invasion
To confirm the effects of stealth si-CD147 on SMMC-7721 cells' invasion, SMMC-7721 cells transfected with si-CD147 or control siRNA were added to the millicell inserts coated with matrigel. The results showed that the invasive cell number was significantly decreased in SMMC-7721 cells transfected with stealth siRNA-CD147 (P < 0.01), and the inhibitory rate . After stealth si-CD147 (HSS141394, HSS141395 and HSS141396) or negative control siRNA being transfected for 48 h, CD147 expression levels were determined by flow cytometric analysis (A) and western blot (B). Identical lysates were reprobed with a GAPDH antibody as a loading control. In stealth si-CD147 transfected cells, CD147 expression was greatly decreased. Fig. 2 . Gelatin zymography analysis of stealth si-CD147 on MMP-2 production in SMMC-7721 cells. ** P < 0.01 v.s. control. SMMC-7721 cells were treated with stealth si-CD147 (HSS141394, HSS141395 and HSS141396) or negative control siRNA for 48 h, and gelatin zymography was used to detect the expression levels of gelatinase. MMP-2 production in SMMC-7721 cells transfected with stealth si-CD147 decreased significantly (A). The graph (B) compares scanning signal intensity of MMP-2 in SMMC-7721 cells transfected with stealth siRNA by ImageJ software analysis system. ** P < 0.01 v.s. control. of HSS141394, HSS141395 and HSS141396 was 100%, 91.2% and 61.8%, respectively (Fig. 4) .
Stealth siRNA against CD147 inhibits FAK and vinculin expression in SMMC-7721 cells The effects of stealth si-CD147 on FAK and vinculin expression in SMMC-7721 cells were assessed by western blot. The results showed that stealth si-CD147 inhibited FAK expression and vinculin expression in SMMC-7721 cells in varying degrees (Fig 5) . Moreover, the inhibitory effect of HSS141394 was most obvious compared to that of others (Fig. 5) .
Discussion
Cell adhesion is very important to cancer metastasis. Cell adhesion to the ECM provides tissue structure and integrity as well as triggers signals that regulate complex biological processes such as cell proliferation, migration and cell cycle (Garcia & Reyes 2005) . Specialized cell-cell and cell-matrix interactions allow communication between cells and the surrounding environment and are critical to cell function (Mason et al. 2002) . Adhesion molecules enable cells to contact and specifically interact with each other. The families of cell adhesion molecules identified to date include selectins, integrins, Ig superfamily members, and cadherins (Friedl & Wolf 2003) . A role for CD147 as an adhesion molecule has been reported to bind to a variety of cell types including endothelial cells and fibroblasts to produce MMPs (Suzuki et al. 2004; Tang et al. 2004) . However, it is not clear whether CD147 is directly involved in cell adhesion or as an adhesion signal transmitting molecule or a regulator of adhesion.
In this study, three stealth TM siRNA duplex oligoribonucleotides CD147 were synthesized and the inhibitory effects were detected. The results showed that three stealth TM siRNA all inhibited SMMC-7721 cell invasion, adhesion and gelatinase production to some extent. However, the comprehensive inhibitory effects of HSS141394 are the best. The difference between different siRNAs in the invasion assay may be related to the percentage of GC. The percentage of GC in HSS141394, HSS141395 and HSS141396 is 60.0%, 48.0% and 52%, respectively. It has been reported that efficient transcription or mRNA processing is responsible for the high expression of GC-rich genes and silent-site GC content correlates with gene expression efficiency in mammalian cells (Kudla et al. 2006) . These findings also indicate that the highly expressed CD147 on the surface of HCC cells plays an important role in the invasiveness and metastasis of HCC. Chen et al (2006) showed that CD147-targeting siRNA significantly downregulated the CD147 mRNA level in melanoma cells and inhibited melanoma cell proliferation, invasiveness, and metastatic activity in vitro and in vivo. Zou et al. (2007) indicated that knockdown of CD147 by short-hairpin RNA resulted in decrease of human ovarian cancer cell line HO-8910pm invasion activity in vitro and tumorigenicity in nude mice. Wang et al. (2006) showed that downregulation of CD147 resulted in reducing secretions of MMP-2, MMP-9 and reduction of invasion ability of prostate tumor cells. Zhou et al. (2005) reported that stealth si-CD147 was found to increase the production of amyloid β-peptides in Alzheimer's disease without changing the expression level of the other γ-secretase components or β-amyloid precursor protein substrates.
Stealth siRNA also inhibited FAK and vinculin expression in SMMC-7721 cells. It suggests that the inhibition of stealth si-CD147 on SMMC-7721 cells adhesion to ECM proteins may be related to FAK-mediated signaling pathway. FAK is a protein tyrosine kinase which is recruited at an early stage to focal adhesions and which mediates many of the downstream responses. FAK expression is crucial to cell migration, spreading, proliferation and survival, and FAK acts as an adaptor protein with multiple protein-protein interaction sites central to the activation of diverse signaling pathways (Ridley et al. 2003) . FAK is over-expressed in HCC and can serve as an independent prognostic factor (Fujii et al. 2004 ). Our previous studies have shown ) that si-HAb18G inhibits gelatinase production, actin and FAK expression in FHCC-98 via an ERK1/2 signaling pathway. Vinculin is a critical component of both cell-cell and cell-matrix complexes and is essential for regulation of cell morphology and migration. Liu et al. (2007) reported that vinculin plays a role in growth regulation of neuroendocrine tumors. Therefore, the inhibition of stealth si-CD147 on SMMC-7721 cell's invasive abilities may be related to downregulaiton of vinculin expression. These findings shed new light on the possibility of FAK, vinculin acting as signal molecules to be involved into the CD147-induced invasion and metastasis of tumor cells. The detailed investigation is currently underway in our laboratory.
In conclusion, stealth si-CD147 inhibited HCC cell line SMMC-7721 invasion, adhesion, gelatinase production, FAK and vinculin expression. Our findings may thus provide new insights for the development of genetherapy technology to treat patients with HCC.
